Contact this trialFirst, we need to learn more about you.
Janus Kinase Inhibitor
Ruxolitinib Cream for Eczema
Recruiting1 awardPhase 3
Miami, Florida
This trial aims to determine how effective ruxolitinib cream is for people with moderate atopic dermatitis who did not respond well to or cannot tolerate topical corticosteroids or calcineur
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.